Articles dans des revues avec comité de lecture (83)

  1. 1. Lan, J., Rajan, N., Bizet, M., Penning, A., Singh, N. K., Guallar, D., Calonne, E., Li Greci, A., Bonvin, E., Deplus, R., Hsu, P. P., Nachtergaele, S., Ma, C., Song, R., Fuentes-Iglesias, A., Hassabi, B., Putmans, P., Mies, F., Menschaert, G., Wong, J. J. L., Wang, J., Fidalgo, M., Yuan, B., & Fuks, F. (2020). Functional role of Tet-mediated RNA hydroxymethylcytosine in mouse ES cells and during differentiation. Nature communications, 11(1), 4956. doi:10.1038/s41467-020-18729-6
  2. 2. Detavernier, A., Azouz, A., Shehade, H., Splittgerber, M., Van Maele, L., Nguyen, M., Thomas, S., Achouri, Y., Svec, D., Calonne, E., Fuks, F., Oldenhove, G., & Goriely, S. (2019). Monocytes undergo multi-step differentiation in mice during oral infection by Toxoplasma gondii. Communications Biology, 2(1), 472. doi:10.1038/s42003-019-0718-6
  3. 3. Istaces, N., Splittgerber, M., Lima Silva, V., Nguyen, M., Thomas, S., Le, A., Achouri, Y., Calonne, E., Defrance, M., Fuks, F., Goriely, S., & Azouz, A. (2019). EOMES interacts with RUNX3 and BRG1 to promote innate memory cell formation through epigenetic reprogramming. Nature communications, 10(1), 3306. doi:10.1038/s41467-019-11233-6
  4. 4. Bonvin, E., Radaelli, E., Bizet, M., Luciani, F., Calonne, E., Putmans, P., Nittner, D., Singh, N. K., Santagostino, S. F., Petit, V., Larue, L., Marine, J.-C., & Fuks, F. (2019). TET2-dependent hydroxymethylome plasticity reduces melanoma initiation and progression. Cancer research, 79(3), 482-494. doi:10.1158/0008-5472.CAN-18-1214
  5. 5. Collignon, E., Canale, A., Al Wardi, C., Bizet, M., Calonne, E., Dedeurwaerder, S., Garaud, S., Naveaux, C., Barham, W., Wilson, A., Bouchat, S., Hubert, P., Van Lint, C., Yull, F., Sotiriou, C., Willard-Gallo, K., Noël, A., & Fuks, F. (2018). Immunity drives TET1 regulation in cancer through NF-κB. Science advances, 4(6), eaap7309. doi:10.1126/sciadv.aap7309
  6. 6. de Bony, E. J., Bizet, M., Van Grembergen, O., Hassabi, B., Calonne, E., Putmans, P., Bontempi, G., & Fuks, F. (2018). Comprehensive identification of long noncoding RNAs in colorectal cancer. Oncotarget, 9(45), 27605-27629. doi:10.18632/oncotarget.25218
  7. 7. Jantsch, M. M., Quattrone, A., O'Connell, M., Helm, M., Frye, M., Macias-Gonzales, M., Ohman, M., Ameres, S., Willems, L., Fuks, F., Oulas, A., Vanacova, S., Nielsen, H., Bousquet-Antonelli, C., Motorin, Y., Roignant, J.-Y., Balatsos, N., Dinnyes, A., Baranov, P., Kelly, V., Lamm, A., Rechavi, G., Pelizzola, M., Liepins, J., Holodnuka Kholodnyuk, I., Zammit, V., Ayers, D., Drablos, F., Dahl, J. A., Bujnicki, J. M., Jeronimo, C., Almeida, R., Neagu, M., Costache, M., Bankovic, J., Banovic, B., Kyselovic, J., Valor, L. M., Selbert, S., Pir, P., Demircan, T., Cowling, V., Schäfer, M., Rossmanith, W., Lafontaine, D., David, A., Carre, C., Lyko, F., Schaffrath, R., Schwartz, S., Verdel, A., Klungland, A., Purta, E., Timotijevic, G., Cardona, F., Davalos, A., Ballana, E., O Carroll, D., Ule, J., & Fray, R. (2018). Positioning Europe for the EPITRANSCRIPTOMICS challenge. RNA biology, 1-3. doi:10.1080/15476286.2018.1460996
  8. 8. Serroukh, Y., Gu-Trantien, C., Hooshiar Kashani, B., Defrance, M., Vu Manh, T.-P., Azouz, A., Detavernier, A., Hoyois, A., Das, J., Bizet, M., Pollet, E., Tabbuso, T., Calonne, E., van Gisbergen, K., Dalod, M., Fuks, F., Goriely, S., & Marchant, A. (2018). The transcription factors Runx3 and ThPOK cross-regulate acquisition of cytotoxic function by human Th1 lymphocytes. eLife, 7. doi:10.7554/eLife.30496
  9. 9. Wang, Y., He, T., Herman, J. J., Linghu, E., Yang, Y., Fuks, F., Zhou, F., Song, L., & Guo, M. (2017). Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth. Clinical Epigenetics, 9(1). doi:10.1186/s13148-017-0417-4
  10. 10. Wang, Y., He, T., Herman, J. J., Linghu, E., Yang, Y., Fuks, F., Zhou, F., Song, L., & Guo, M. (2017). Correction: Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth [Clin Epigenetics. 9, (2017), (115)] DOI: 10.1186/s13148-017-0417-4. Clinical Epigenetics, 9(1). doi:10.1186/s13148-018-0467-2
  11. 11. Guo, Y., Peng, Y., Gao, D., Zhang, M., Yang, W., Linghu, E., Herman, J. J., Fuks, F., Dong, G., & Guo, M. (2017). Silencing HOXD10 by promoter region hypermethylation activates ERK signaling in hepatocellular carcinoma. Clinical Epigenetics, 9(1), 116. doi:10.1186/s13148-017-0412-9
  12. 12. Jeschke, J., Bizet, M., Desmedt, C., Calonne, E., Dedeurwaerder, S., Garaud, S., Koch, A., Larsimont, D., Salgado, R., Van den Eynden, G., Willard-Gallo, K., Bontempi, G., Defrance, M., Sotiriou, C., & Fuks, F. (2017). DNA methylation-based immune response signature improves patient diagnosis in multiple cancers. The Journal of clinical investigation, 127(8), 3090-3102. doi:10.1172/JCI91095

  13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 Suivant >>